NICE FH guideline
Summary of NICE guidance on the identification and management of familial hypercholesterolaemia, which includes diagnostic criteria and when to refer.
NICE hypertension guideline
A brief guide on the diagnosis and management of hypertension, includes visual summaries on treatment and choice of antihypertensive drug.
NICE stroke and TIA guideline
This concise summary covers the rapid recognition of symptoms and diagnosis of stroke and transient ischaemic attack.
NICE hypertension in pregnancy guideline
This summary covers the diagnosis and management of hypertension during pregnancy, labour, and birth.
SIGN cardiac arrhythmias guideline
Read the latest recommendations on the management of atrial fibrillation and ventricular arrhythmias in acute coronary syndrome, coronary heart disease, and left-ventricular dysfunction as well as arrhythmias associated with cardiac arrest and coronary artery bypass graft.
Educational resources
NICE Technology Appraisal 607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
The production of this Guidelines card has been commissioned by Bayer plc. Bayer plc has reviewed the card for technical accuracy and regulatory compliance and supplied the prescribing information.
Xarelto® ▼ (rivaroxaban) SMC2128
The production of this Guidelines card has been commissioned by Bayer plc. Bayer plc has reviewed this card for technical accuracy and regulatory compliance. The SMC has reviewed this card for technical accuracy and permission request only. The SMC were not involved in the production of this card.
Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment
This NOAC dosing guide has been commissioned by Bayer, who also provided funding for its development. Bayer reviewed and approved the scope and pre-meeting documents, suggested the Chair and experts for the group, and put the dosing guide through full medical approval to ensure its compliance with appropriate regulations.
Related Guidelines in Practice articles
-
Cardiac arrhythmia: risk factors for heart disease need to be addressed
Dr Alan Begg summarises recommendations in SIGN’s latest guidance on cardiac arrhythmias that are relevant to primary care and highlights some major advances in treatment
-
Mechanical thrombectomy: a new treatment for stroke
Dr Dipankar Dutta discusses some important aspects of mechanical thrombectomy and implications for the NHS and primary care clinicians and commissioners
-
Stable angina: how does the SIGN guideline compare with NICE?
Dr Alan Begg compares SIGN and NICE recommendations on the diagnosis, assessment, and treatment of stable angina
-
Top tips: cardiotoxicity and cancer
Dr Sinead Clarke and Dr Nicola Harker provide top tips on mitigating the impact of cancer treatment on cardiovascular health
-
Top tips: stroke prevention
Professor Jonathan Mant summarises top tips for patients and practitioners on stroke risk assessment and reduction